Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker GILD
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Wettan Keeley M. Cain EVP Gen Counsel, Legal & Comp | GILD Gilead Sciences, Inc. | Sale | 3,399 | $164.11 | $557.8K Sale | Form 4 ↗ |
| Nov 5, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 9,810 | $175.17 | $1.7M Sale | Form 4 ↗ |
| Nov 4, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 102,619 | $175.16 | $18.0M Sale | Form 4 ↗ |
| Nov 2, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 2,000 | $171.06 | $342.1K Sale | Form 4 ↗ |
| Nov 2, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 7,796 | $170.35 | $1.3M Sale | Form 4 ↗ |
| Nov 2, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 1,904 | $169.27 | $322.3K Sale | Form 4 ↗ |
| Nov 2, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 1,700 | $168.10 | $285.8K Sale | Form 4 ↗ |
| Nov 2, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 1,600 | $167.40 | $267.8K Sale | Form 4 ↗ |
| Oct 30, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 15,881 | $175.25 | $2.8M Sale | Form 4 ↗ |
| Oct 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $156.22 | $468.7K Sale | Form 4 ↗ |
| Oct 15, 2026 | Andrew D. Dickinson Chief Financial Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $156.22 | $468.7K Sale | Form 4 ↗ |
| Sep 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 600 | $145.29 | $87.2K Sale | Form 4 ↗ |
| Sep 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 800 | $144.46 | $115.6K Sale | Form 4 ↗ |
| Sep 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 1,600 | $143.69 | $229.9K Sale | Form 4 ↗ |
| Sep 15, 2026 | Andrew D. Dickinson Chief Financial Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $145.29 | $435.9K Sale | Form 4 ↗ |
| Sep 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 5,408 | $149.38 | $807.8K Sale | Form 4 ↗ |
| Sep 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 7,992 | $148.36 | $1.2M Sale | Form 4 ↗ |
| Sep 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 1,600 | $147.51 | $236.0K Sale | Form 4 ↗ |
| Aug 26, 2026 | Anthony Welters Director | GILD Gilead Sciences, Inc. | Sale | 6,880 | $148.82 | $1.0M Sale | Form 4 ↗ |
| Aug 26, 2026 | Anthony Welters Director | GILD Gilead Sciences, Inc. | Sale | 3,402 | $148.24 | $504.3K Sale | Form 4 ↗ |
| Aug 26, 2026 | Anthony Welters Director | GILD Gilead Sciences, Inc. | Sale | 4,600 | $148.82 | $684.6K Sale | Form 4 ↗ |
| Aug 26, 2026 | Anthony Welters Director | GILD Gilead Sciences, Inc. | Sale | 3,118 | $148.31 | $462.4K Sale | Form 4 ↗ |
| Aug 20, 2026 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | Sale | 335 | $146.26 | $49.0K Sale | Form 4 ↗ |
| Aug 20, 2026 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | Sale | 26 | $146.36 | $3,805 Sale | Form 4 ↗ |
| Aug 20, 2026 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | Sale | 1,658 | $145.73 | $241.6K Sale | Form 4 ↗ |
| Aug 20, 2026 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | Sale | 1,816 | $144.92 | $263.2K Sale | Form 4 ↗ |
| Aug 20, 2026 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | Sale | 1,165 | $143.75 | $167.5K Sale | Form 4 ↗ |
| Aug 17, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 11,470 | $138.04 | $1.6M Sale | Form 4 ↗ |
| Aug 17, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 16,530 | $137.37 | $2.3M Sale | Form 4 ↗ |
| Aug 17, 2026 | Andrew D. Dickinson Chief Financial Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $138.36 | $415.1K Sale | Form 4 ↗ |
| Aug 3, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 600 | $131.34 | $78.8K Sale | Form 4 ↗ |
| Aug 3, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 7,700 | $130.80 | $1.0M Sale | Form 4 ↗ |
| Aug 3, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 6,700 | $129.66 | $868.7K Sale | Form 4 ↗ |
| Jul 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $129.92 | $389.8K Sale | Form 4 ↗ |
| Jul 15, 2026 | Andrew D. Dickinson Chief Financial Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $129.93 | $389.8K Sale | Form 4 ↗ |
| Jul 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 3,100 | $127.08 | $393.9K Sale | Form 4 ↗ |
| Jul 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 11,900 | $126.09 | $1.5M Sale | Form 4 ↗ |
| Jun 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 450 | $125.40 | $56.4K Sale | Form 4 ↗ |
| Jun 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 1,070 | $124.00 | $132.7K Sale | Form 4 ↗ |
| Jun 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 1,480 | $123.42 | $182.7K Sale | Form 4 ↗ |
| Jun 15, 2026 | Andrew D. Dickinson Chief Financial Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $125.40 | $376.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 1,038 | $132.97 | $138.0K Sale | Form 4 ↗ |
| Jun 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 3,062 | $132.22 | $404.9K Sale | Form 4 ↗ |
| Jun 1, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 10,900 | $131.10 | $1.4M Sale | Form 4 ↗ |
| May 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 700 | $132.75 | $92.9K Sale | Form 4 ↗ |
| May 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 8,374 | $132.23 | $1.1M Sale | Form 4 ↗ |
| May 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 11,177 | $131.19 | $1.5M Sale | Form 4 ↗ |
| May 15, 2026 | Johanna Mercier Chief Comm & Corp Aff Officer | GILD Gilead Sciences, Inc. | Sale | 7,749 | $130.29 | $1.0M Sale | Form 4 ↗ |
| May 15, 2026 | Andrew D. Dickinson Chief Financial Officer | GILD Gilead Sciences, Inc. | Sale | 3,000 | $132.27 | $396.8K Sale | Form 4 ↗ |
| Apr 28, 2026 | Daniel Patrick O'Day Chairman & CEO, Director | GILD Gilead Sciences, Inc. | Sale | 3,050 | $130.01 | $396.5K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 8:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances